Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schauf, C. L.
Right arrow Articles by Rooney, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schauf, C. L.
Right arrow Articles by Rooney, M. W.
NEUROLOGY 1980;30:1011
© 1980 American Academy of Neurology

Neuroelectric blocking activity and plasmapheresis in amyotrophic lateral sclerosis

C. L. Schauf, J. P. Antel, B. G. W. Arnason, F. A. Davis and M. W. Rooney

From the Departments of Physiology and Neurological Sciences (Drs. Schauf, Davis and Rooney), Rush University, and the Department of Neurology, Pritzker School of Medicine (Drs. Antel and Amason), University of Chicago, Chicago, IL.

Neuroelectric blocking activity, similar in nature to that previously observed in sera from patients with multiple sclerosis, has been observed in sera from 18 patients with amyotrophic lateral sclerosis. Results concerning the application of plasma exchange to this patient population are also described.

This work was supported by Research Career Development Award No. K04NS00004 (Dr Schauf), by National Multiple Sclerosis Society grant No. RG1230A1 (Dr. Schauf), the Morris Multiple Sclerosis Research Fund (Dr. Davis), and grants from the Muscular Dystrophy Association of America (Dr. Antel) and the Amyotrophic Lateral Sclerosis Society of America (Dr. Arnason).

Address correspondence and reprint requests to Dr. Schauf, Department of Physiology, Rush University, Chicago, IL 60637.

Accepted for publication November 9, 1979.




This article has been cited by other articles:


Home page
 Arch NeurolHome page
H. Mitsumoto, M. R. Hanson, and D. A. Chad
Amyotrophic Lateral Sclerosis: Recent Advances in Pathogenesis and Therapeutic Trials
Arch Neurol, February 1, 1988; 45(2): 189 - 202.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
R. H. Brown Jr, S. L. Hauser, H. Harrington, and H. L. Weiner
Failure of Immunosuppression With a Ten- to 14-Day Course of High-Dose Intravenous Cyclophosphamide to Alter the Progression of Amyotrophic Lateral Sclerosis
Arch Neurol, April 1, 1986; 43(4): 383 - 384.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
P. C. Dau
Plasmapheresis: Therapeutic or Experimental Procedure?
Arch Neurol, June 1, 1984; 41(6): 647 - 653.
[Abstract] [PDF]